AtriCure, Inc. (ATRC) is a publicly traded Healthcare sector company. As of October 26, 2026, ATRC trades at $59.57 with a market cap of $3.00B and a P/E ratio of 252.84. ATRC moved +1.49% today. Year to date, ATRC is +49.06%; over the trailing twelve months it is +57.72%. Its 52-week range spans $25.36 to $61.70. Analyst consensus is strong buy with an average price target of $60.25. Rallies surfaces ATRC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest ATRC news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $59.57 |
| Market Cap | $3.00B |
| P/E Ratio | 252.84 |
| EPS | $0.21 |
| Dividend Yield | 0.00% |
| 52-Week High | $61.70 |
| 52-Week Low | $25.36 |
| Volume | 61.61K |
| Avg Volume | 0 |
| Revenue (TTM) | $569.62M |
| Net Income | $10.55M |
| Gross Margin | 76.30% |
8 analysts cover ATRC: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $60.25.